学术探索
学术期刊
新闻热点
数据分析
智能评审

Cytochrome p450 enzymes: Interpretation of their interactions with selective serotonin reuptake inhibitors .1.

被引：74
作者：
Harvey, AT [1 ]
Preskorn, SH [1 ]
机构：
[1] UNIV KANSAS, SCH MED, DEPT PSYCHIAT, WICHITA, KS 67214 USA
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 1996年 / 16卷 / 04期
关键词：
D O I：
10.1097/00004714-199608000-00002
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：273 / 285
页数：13
相关论文
共 130 条
  • [1] OMEPRAZOLE DRUG-INTERACTION STUDIES
    ANDERSSON, T
    [J]. CLINICAL PHARMACOKINETICS, 1991, 21 (03) : 195 - 212
  • [2] ANDERSSON T, 1994, CLIN PHARMACOL THER, V55, P138
  • [3] GENETIC-FACTORS INFLUENCING THE METABOLISM OF TOLBUTAMIDE
    BACK, DJ
    ORME, ML
    [J]. PHARMACOLOGY & THERAPEUTICS, 1989, 44 (02) : 147 - 155
  • [4] ROLE OF OXIDATION POLYMORPHISM ON BLOOD AND URINE CONCENTRATIONS OF AMITRIPTYLINE AND ITS METABOLITES IN MAN
    BALANTGORGIA, AE
    SCHULZ, P
    DAYER, P
    BALANT, L
    KUBLI, A
    GERTSCH, C
    GARRONE, G
    [J]. ARCHIV FUR PSYCHIATRIE UND NERVENKRANKHEITEN, 1982, 232 (03): : 215 - 222
  • [5] IMPORTANCE OF OXIDATIVE POLYMORPHISM AND LEVOMEPROMAZINE TREATMENT ON THE STEADY-STATE BLOOD-CONCENTRATIONS OF CLOMIPRAMINE AND ITS MAJOR METABOLITES
    BALANTGORGIA, AE
    BALANT, LP
    GENET, C
    DAYER, P
    AESCHLIMANN, JM
    GARRONE, G
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (04) : 449 - 455
  • [6] AMITRIPTYLINE PHARMACOKINETICS AND CLINICAL-RESPONSE .2. METABOLIC POLYMORPHISM ASSESSED BY HYDROXYLATION OF DEBRISOQUINE AND MEPHENYTOIN
    BAUMANN, P
    JONZIERPEREY, M
    KOEB, L
    KUPFER, A
    TINGUELY, D
    SCHOPF, J
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1986, 1 (02) : 102 - 112
  • [7] THE DEBRISOQUINE HYDROXYLATION TEST PREDICTS STEADY-STATE PLASMA-LEVELS OF DESIPRAMINE
    BERTILSSON, L
    ABERGWISTEDT, A
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (03) : 388 - 390
  • [8] IMPORTANCE OF GENETIC-FACTORS IN THE REGULATION OF DIAZEPAM METABOLISM - RELATIONSHIP TO S-MEPHENYTOIN, BUT NOT DEBRISOQUIN, HYDROXYLATION PHENOTYPE
    BERTILSSON, L
    HENTHORN, TK
    SANZ, E
    TYBRING, G
    SAWE, J
    VILLEN, T
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (04) : 348 - 355
  • [9] CLINICAL PHARMACOKINETICS AND PHARMACOLOGICAL EFFECTS OF CARBAMAZEPINE AND CARBAMAZEPINE-10,11-EPOXIDE - AN UPDATE
    BERTILSSON, L
    TOMSON, T
    [J]. CLINICAL PHARMACOKINETICS, 1986, 11 (03) : 177 - 198
  • [10] PURIFICATION OF A DESMETHYLIMIPRAMINE AND DEBRISOQUINE HYDROXYLATING CYTOCHROME-P-450 FROM HUMAN-LIVER
    BIRGERSSON, C
    MORGAN, ET
    JORNVALL, H
    VONBAHR, C
    [J]. BIOCHEMICAL PHARMACOLOGY, 1986, 35 (18) : 3165 - 3166
12345678910